Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2026-06-04 16:14:41 ET · period of report 2026-06-01 · accession 0001470831-26-000504 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-04 16:14 | 2026-06-01 | CCCC | Anderson Kenneth Carl | Dir | M - OptEx | $2.11 | +1,070 | 69.3K | +2% | +$2,258 |
| D | 2026-06-04 16:14 | 2026-06-01 | CCCC | Anderson Kenneth Carl | Dir | M - OptEx | $0.00 | -1,070 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | M | A | 1,070 | $2.11 | 69,300 | D | — | — | (F1) The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-01 | M | D | 1,070 | $0.00 | 0 | D | $2.11 · — to 2026-07-12 | 1,070 Common Stock | (F1) The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise. (F7) The shares underlying this option are fully vested and exercisable. |